Clinical Trial Update: A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients Switched From EC-MPS. [Phase 4]

View source ↗

Summary

Phase 4 trial update indicating termination of a study evaluating CellCept (mycophenolate mofetil) in kidney transplant patients switched from EC-MPS. Sponsor: …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Kidney Transplantation | Phase 4 | Status: TERMINATED